HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PEGBIO CO-B

5.875

-0.100-1.67%

Volume:4.99M

Turnover:29.58M

Market Cap:2.30B

PE:-10.68

High:6.040

Open:5.990

Low:5.870

Close:5.975

52wk High:77.000

52wk Low:4.940

Shares:391.00M

HK Float Shares:386.00M

Volume Ratio:0.36

T/O Rate:1.29%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.550

ROE:-82.42%

ROA:-31.46%

PB:4.39

PE(LYR):-10.68

PS:-508.02

Loading ...

Overview Company News Filings

Movement Alert｜PegBio Rises 8.42% in Regular Trading, Rani Therapeutics Oral Delivery Partnership Continues to Fuel Market Enthusiasm

Movement Alert｜PegBio Rises 38.16% in Regular Trading, Partners with Rani Therapeutics to Advance Oral Delivery of Metabolic Assets

PEGBIO Shares Surge Over 21% on Oral Delivery Collaboration with Rani Therapeutics

PegBio Partners with Rani: Oral Delivery Platform Opens Global Revaluation Path for Next-Generation Metabolic Assets

Pegbio Co - Enters Mou with Nasdaq-listed Rani Therapeutics

THOMSON REUTERS

Pegbio Co - Collaboration to Advance Oral Delivery of Multiple Metabolic Assets

THOMSON REUTERS

Rani Therapeutics Partners with Pegbio to Develop Oral Obesity Drug Candidates

PEGBIO Shares Surge on Positive Progress for Diabetes Drug in National Reimbursement Review

Movement Alert｜PegBio-B Falls 8.3% in Regular Trading, Continued Volatility After H-Share Full Circulation Completion

PegBio’s Visepegenatide Injection Clears Preliminary Hurdle for 2026 China NRDL Inclusion

Bulletin Express

PEGBIO's Key Drug Vipenatide Injection Clears Initial Review for 2026 National Reimbursement List

Movement Alert｜PegBio Rises 17.94% in Regular Trading, Stock Rebounds from Historic Low After H-Share Full Circulation Selloff

PegBio Completes H-Share Full Circulation

MT Newswires Live

Movement Alert｜PegBio Pharmaceutical-B Falls 8.19% in Regular Trading, H-Share Full Circulation Completed with Over 100 Million Shares Newly Listed

PEGBIO CO-B Completes Full H-Share Conversion for Trading

PegBio Converts 101.70 Million Unlisted Shares into H Shares, Enlarging Hong Kong Free Float by 26%

Bulletin Express

Pegbio Appoints Yik Lam Liao as Independent Director, Names Her Audit Chair

Movement Alert｜Pegbio Biopharmaceuticals-B Falls 8.23% in Regular Trading, Litigation Risk and Sector Weakness Intensify Selling Pressure

PegBio Receives HK$61 Million in Royalty Payment Over Drug Licensing Deal

MT Newswires Live

Movement Alert｜PegBio Rises 8.37% in Regular Trading, Boosted by HKD 61 Million Commercialization Milestone Payment from Tengrui Pharma

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/02565/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"PEGBIO CO-B","latestPrice":5.875,"timestamp":1787299688008,"preClose":5.975,"halted":0,"volume":4987250,"delay":0,"changeRate":-0.01673640167364011,"floatShares":386000000,"shares":391000000,"eps":-0.55,"marketStatus":"Market Closed","change":-0.1,"latestTime":"08-21 16:08:08","open":5.99,"high":6.04,"low":5.87,"amount":29583125,"amplitude":0.028452,"askPrice":5.9,"askSize":600,"bidPrice":5.875,"bidSize":23100,"shortable":3,"etf":0,"ttmEps":-0.612785,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":5.975,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.35780179890285707,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":386000000,"roa":"-31.46%","roe":"-82.42%","lyrEps":-0.55,"volumeRatio":0.35780179890285707,"shares":391000000,"dividePrice":0,"high":6.04,"amplitude":0.028452,"preClose":5.975,"low":5.87,"week52Low":4.94,"pbRate":"4.39","psRate":"-508.02","week52High":77,"institutionHeld":0,"latestPrice":5.875,"committee":0.949367,"eps":-0.55,"divideRate":0,"volume":4987250,"delay":0,"ttmEps":-0.612785,"open":5.99,"prevYearClose":69,"prevWeekClose":6.23,"prevMonthClose":5.36,"prevQuarterClose":5.33,"fiveDayClose":6.23,"twentyDayClose":6.39,"sixtyDayClose":8.82,"earningDate":1787587200000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02565","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-26","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2026-08-21","current":-9.587376,"percent":0.935811,"low":-87.782868,"twenty":-72.846173,"median":-58.454271,"eighty":-11.546541,"high":-7.824338,"avg":-44.305288,"sd":28.056716,"marketCap":2297662750},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426},{"date":"2025-06-06","current":-11.987888,"twenty":-13.726785,"median":-12.740515,"eighty":-12.114178,"marketCap":3712892217},{"date":"2025-06-13","current":-11.23576,"twenty":-13.295707,"median":-12.114337,"eighty":-11.528404,"marketCap":3481318898},{"date":"2025-06-20","current":-11.30775,"twenty":-12.841258,"median":-11.963331,"eighty":-11.337793,"marketCap":3496757119},{"date":"2025-06-27","current":-12.421214,"twenty":-12.738977,"median":-11.541778,"eighty":-11.292079,"marketCap":3851836209},{"date":"2025-07-04","current":-13.963875,"twenty":-12.971799,"median":-11.987888,"eighty":-11.299391,"marketCap":4330421069},{"date":"2025-07-11","current":-13.604213,"twenty":-13.050401,"median":-12.199189,"eighty":-11.305737,"marketCap":4214634409},{"date":"2025-07-18","current":-16.956264,"twenty":-13.748078,"median":-12.438987,"eighty":-11.330282,"marketCap":5248995235},{"date":"2025-07-25","current":-19.006677,"twenty":-15.472199,"median":-12.742066,"eighty":-11.352726,"marketCap":5905119639},{"date":"2025-08-01","current":-19.199848,"twenty":-18.276271,"median":-12.906561,"eighty":-11.424474,"marketCap":5928276971},{"date":"2025-08-08","current":-20.51103,"twenty":-19.019895,"median":-13.05938,"eighty":-11.472546,"marketCap":6348968501},{"date":"2025-08-15","current":-39.959751,"twenty":-19.179784,"median":-13.542645,"eighty":-11.515029,"marketCap":12350577024},{"date":"2025-08-22","current":-41.864246,"twenty":-19.284777,"median":-13.964282,"eighty":-11.779976,"marketCap":12898633879},{"date":"2025-08-29","current":-41.44792,"twenty":-21.432837,"median":-14.946806,"eighty":-11.968242,"marketCap":10033166343},{"date":"2025-09-05","current":-50.678037,"twenty":-39.039264,"median":-17.018603,"eighty":-12.06328,"marketCap":12255314482},{"date":"2025-09-12","current":-58.538001,"twenty":-40.749762,"median":-18.438762,"eighty":-12.114019,"marketCap":14181548421},{"date":"2025-09-19","current":-57.311117,"twenty":-43.720929,"median":-18.952908,"eighty":-12.216159,"marketCap":13874467648},{"date":"2025-09-26","current":-63.587749,"twenty":-49.33228,"median":-19.070122,"eighty":-12.366345,"marketCap":15354038645},{"date":"2025-10-03","current":-60.149194,"twenty":-54.575673,"median":-19.16943,"eighty":-12.428323,"marketCap":14558420278},{"date":"2025-10-10","current":-60.121463,"twenty":-57.957283,"median":-19.199848,"eighty":-12.49878,"marketCap":14530503844},{"date":"2025-10-17","current":-60.168303,"twenty":-59.756564,"median":-19.2984,"eighty":-12.738571,"marketCap":14530503844},{"date":"2025-10-24","current":-61.301982,"twenty":-60.143648,"median":-20.51103,"eighty":-12.741458,"marketCap":14809668183},{"date":"2025-10-31","current":-69.345185,"twenty":-60.159469,"median":-22.018639,"eighty":-12.743079,"marketCap":16777776773},{"date":"2025-11-07","current":-59.401661,"twenty":-60.392128,"median":-34.33922,"eighty":-12.780248,"marketCap":14363005241},{"date":"2025-11-14","current":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"marketCap":17657144441},{"date":"2025-11-21","current":-72.852961,"twenty":-61.301982,"median":-40.866122,"eighty":-12.943343,"marketCap":17657144441},{"date":"2025-11-28","current":-82.344376,"twenty":-62.346137,"median":-42.423494,"eighty":-13.014482,"marketCap":20030041323},{"date":"2025-12-05","current":-72.063717,"twenty":-63.355663,"median":-45.122001,"eighty":-13.104279,"marketCap":17559436923},{"date":"2025-12-12","current":-74.217813,"twenty":-64.460997,"median":-48.969529,"eighty":-13.233973,"marketCap":18117765601},{"date":"2025-12-19","current":-71.875632,"twenty":-65.413889,"median":-52.055133,"eighty":-13.542645,"marketCap":17587353357},{"date":"2025-12-24","current":-73.927127,"twenty":-69.382811,"median":-55.337969,"eighty":-13.579586,"marketCap":18145682035},{"date":"2026-01-02","current":-79.895405,"twenty":-70.540926,"median":-57.311117,"eighty":-13.748078,"marketCap":19687798475},{"date":"2026-01-09","current":-85.854057,"twenty":-72.056904,"median":-58.941314,"eighty":-13.964201,"marketCap":21208805289},{"date":"2026-01-16","current":-80.413876,"twenty":-72.839385,"median":-59.401661,"eighty":-14.164153,"marketCap":19929453763},{"date":"2026-01-23","current":-77.735339,"twenty":-73.262106,"median":-59.808211,"eighty":-14.656731,"marketCap":19247132950},{"date":"2026-01-30","current":-73.838267,"twenty":-73.550435,"median":-60.0941,"eighty":-15.472199,"marketCap":18365801899},{"date":"2026-02-06","current":-69.490034,"twenty":-73.32273,"median":-60.154331,"eighty":-16.538679,"marketCap":17328105662},{"date":"2026-02-13","current":-71.473742,"twenty":-73.562339,"median":-60.192909,"eighty":-17.006135,"marketCap":17925136373},{"date":"2026-02-20","current":-71.065981,"twenty":-73.716985,"median":-60.392128,"eighty":-17.056006,"marketCap":17797201221},{"date":"2026-02-27","current":-72.540901,"twenty":-73.438012,"median":-60.796223,"eighty":-17.950543,"marketCap":18365801899},{"date":"2026-03-06","current":-68.036226,"twenty":-73.352041,"median":-61.160082,"eighty":-18.384598,"marketCap":17086450373},{"date":"2026-03-13","current":-60.794114,"twenty":-73.299371,"median":-60.919795,"eighty":-18.597951,"marketCap":15338003289},{"date":"2026-03-20","current":-67.303035,"twenty":-73.275932,"median":-61.206433,"eighty":-18.84686,"marketCap":16915870170},{"date":"2026-03-27","current":-68.867925,"twenty":-73.269478,"median":-61.274827,"eighty":-18.985169,"marketCap":16247764373},{"date":"2026-04-02","current":-85.055535,"twenty":-73.278872,"median":-61.433108,"eighty":-19.026504,"marketCap":20163286400},{"date":"2026-04-10","current":-78.454069,"twenty":-73.369897,"median":-61.662876,"eighty":-19.045802,"marketCap":18741784705},{"date":"2026-04-17","current":-76.94604,"twenty":-73.948705,"median":-62.45145,"eighty":-19.079188,"marketCap":18389252284},{"date":"2026-04-24","current":-60.4786,"twenty":-73.948705,"median":-62.528681,"eighty":-19.126247,"marketCap":14454535592},{"date":"2026-05-15","current":-17.642518,"twenty":-73.927127,"median":-62.346137,"eighty":-19.115451,"marketCap":4376314243},{"date":"2026-05-22","current":-20.448357,"twenty":-73.838267,"median":-61.433108,"eighty":-19.16943,"marketCap":5060724424},{"date":"2026-05-29","current":-13.590249,"twenty":-73.716985,"median":-61.274827,"eighty":-19.064042,"marketCap":3375119921},{"date":"2026-06-05","current":-12.579887,"twenty":-73.438012,"median":-61.206433,"eighty":-18.597951,"marketCap":3128732256},{"date":"2026-06-12","current":-11.565594,"twenty":-73.352041,"median":-60.919795,"eighty":-17.056006,"marketCap":2874522760},{"date":"2026-06-18","current":-9.622776,"twenty":-73.31105,"median":-60.791238,"eighty":-14.753422,"marketCap":2397391091},{"date":"2026-06-26","current":-7.824338,"twenty":-73.278872,"median":-60.512398,"eighty":-13.899973,"marketCap":1939813998},{"date":"2026-07-03","current":-8.984958,"twenty":-73.271235,"median":-60.431019,"eighty":-13.561687,"marketCap":2229221732},{"date":"2026-07-10","current":-11.252888,"twenty":-73.25947,"median":-60.210807,"eighty":-13.050401,"marketCap":2788482623},{"date":"2026-07-17","current":-10.458113,"twenty":-73.235067,"median":-60.159469,"eighty":-12.830773,"marketCap":2600758687},{"date":"2026-07-24","current":-10.046967,"twenty":-73.215248,"median":-60.107782,"eighty":-12.739192,"marketCap":2499074889},{"date":"2026-07-31","current":-8.411523,"twenty":-73.183292,"median":-59.862622,"eighty":-12.522041,"marketCap":2096250611},{"date":"2026-08-07","current":-10.298244,"twenty":-73.061453,"median":-59.675079,"eighty":-12.306772,"marketCap":2571426822},{"date":"2026-08-14","current":-9.745542,"twenty":-72.966779,"median":-59.367669,"eighty":-11.991332,"marketCap":2436500244},{"date":"2026-08-21","current":-9.169953,"twenty":-72.846173,"median":-58.454271,"eighty":-11.546541,"marketCap":2297662750}],"updateTime":1787465708401},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02565\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1184828201","title":"Movement Alert｜PegBio Rises 8.42% in Regular Trading, Rani Therapeutics Oral Delivery Partnership Continues to Fuel Market Enthusiasm","url":"https://stock-news.laohu8.com/highlight/detail?id=1184828201","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184828201?lang=en_us&edition=fundamental","pubTime":"2026-07-13 09:46","pubTimestamp":1783907175,"startTime":"0","endTime":"0","summary":"On July 13, PegBio (02565.HK) rose 8.42% in regular trading, trading at HKD 7.29/share, with turnover of HKD 108 million, extending the strong rally momentum from the previous Friday.The sustained...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147750283","title":"Movement Alert｜PegBio Rises 38.16% in Regular Trading, Partners with Rani Therapeutics to Advance Oral Delivery of Metabolic Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=1147750283","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147750283?lang=en_us&edition=fundamental","pubTime":"2026-07-10 11:09","pubTimestamp":1783652958,"startTime":"0","endTime":"0","summary":"On July 10, PegBio (02565.HK) surged 38.16% in regular trading, reaching HKD 7.64 per share, with turnover of HKD 530 million. The stock opened sharply higher and continued to strengthen throughout...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136807453","title":"PEGBIO Shares Surge Over 21% on Oral Delivery Collaboration with Rani Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=1136807453","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136807453?lang=en_us&edition=fundamental","pubTime":"2026-07-10 09:40","pubTimestamp":1783647629,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (ASX: 02565) shares experienced a significant surge of over 21% in today's trading session. At the time of writing, the stock was up 21.88% to HK$6.77, with a trading volume of HK$60.81...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","399441","KCAI","VXUS","BK1161","XBI","02565","BK4581","BK4588","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155519004","title":"PegBio Partners with Rani: Oral Delivery Platform Opens Global Revaluation Path for Next-Generation Metabolic Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=1155519004","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155519004?lang=en_us&edition=fundamental","pubTime":"2026-07-10 08:50","pubTimestamp":1783644628,"startTime":"0","endTime":"0","summary":"Following the commercialization of its core product Vipenatide, PegBio is adding new product forms and overseas development pathways for its next-generation metabolic innovation pipeline.It has been...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650704749","title":"Pegbio Co - Enters Mou with Nasdaq-listed Rani Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2650704749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650704749?lang=en_us&edition=fundamental","pubTime":"2026-07-10 08:00","pubTimestamp":1783641649,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43B0M6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650420970","title":"Pegbio Co - Collaboration to Advance Oral Delivery of Multiple Metabolic Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2650420970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650420970?lang=en_us&edition=fundamental","pubTime":"2026-07-10 08:00","pubTimestamp":1783641649,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43B0M6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650974640","title":"Rani Therapeutics Partners with Pegbio to Develop Oral Obesity Drug Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2650974640","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650974640?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:11","pubTimestamp":1783627893,"startTime":"0","endTime":"0","summary":"Rani Therapeutics partners with PegBio to develop oral obesity drug candidatesRani Therapeutics entered an R&D collaboration with PegBio to develop oral RaniPill formulations for multiple obesity and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL2Yk8gq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI","BK4007","BK4539","02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116321689","title":"PEGBIO Shares Surge on Positive Progress for Diabetes Drug in National Reimbursement Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1116321689","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116321689?lang=en_us&edition=fundamental","pubTime":"2026-07-02 13:46","pubTimestamp":1782971187,"startTime":"0","endTime":"0","summary":" Shares of PEGBIO CO-B (ASX: 02565) rose more than 5%, trading up 4.13% at HK$5.55 by the latest update, with a turnover of HK$39.02 million. Key Development The company recently announced that its...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","VXUS","BK4581","161726","399441","BK4585","02565","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132087722","title":"Movement Alert｜PegBio-B Falls 8.3% in Regular Trading, Continued Volatility After H-Share Full Circulation Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=1132087722","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132087722?lang=en_us&edition=fundamental","pubTime":"2026-06-30 10:47","pubTimestamp":1782787621,"startTime":"0","endTime":"0","summary":"On June 30, PegBio-B (02565.HK) declined 8.3% in regular trading, trading at HK$5.31/share, with turnover of approximately HK$26.38 million.The decline is attributed to ongoing selling pressure...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104589736","title":"PegBio’s Visepegenatide Injection Clears Preliminary Hurdle for 2026 China NRDL Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=1104589736","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104589736?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:04","pubTimestamp":1782731082,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. (PegBio) announced that its core product Visepegenatide injection (trade name: Paidakang®) has been placed on the National Healthcare Security Administration’s list of drugs that...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105233104","title":"PEGBIO's Key Drug Vipenatide Injection Clears Initial Review for 2026 National Reimbursement List","url":"https://stock-news.laohu8.com/highlight/detail?id=1105233104","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105233104?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:30","pubTimestamp":1782729038,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (ASX: 02565) has announced that its core product, Vipenatide Injection (brand name: Paidakang®), has been included in the preliminary formal review list for the 2026 National...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","399441","BK4581","02565","BK1161","BK4585","161726","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110775924","title":"Movement Alert｜PegBio Rises 17.94% in Regular Trading, Stock Rebounds from Historic Low After H-Share Full Circulation Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=1110775924","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110775924?lang=en_us&edition=fundamental","pubTime":"2026-06-29 11:08","pubTimestamp":1782702519,"startTime":"0","endTime":"0","summary":"On June 29, PegBio rose 17.94% in regular trading, trading at HK$5.86/share, with turnover of HK$97.03 million.On the news front, the company completed its H-share full circulation on June 25,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646602339","title":"PegBio Completes H-Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2646602339","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646602339?lang=en_us&edition=fundamental","pubTime":"2026-06-26 13:54","pubTimestamp":1782453247,"startTime":"0","endTime":"0","summary":"PegBio (HKG:2565) completed its planned H-share full circulation in Hong Kong, according to a Friday bourse filing.The biopharmaceutical company converted and listed about 101.7 million previously unlisted shares into H-shares under the full-circulation scheme.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158003214","title":"Movement Alert｜PegBio Pharmaceutical-B Falls 8.19% in Regular Trading, H-Share Full Circulation Completed with Over 100 Million Shares Newly Listed","url":"https://stock-news.laohu8.com/highlight/detail?id=1158003214","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158003214?lang=en_us&edition=fundamental","pubTime":"2026-06-26 13:41","pubTimestamp":1782452479,"startTime":"0","endTime":"0","summary":"On June 26, PegBio Pharmaceutical-B declined 8.19% in regular trading, trading at HK$5.25 per share, with turnover of approximately HK$41.46 million.On the news front, the company announced the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114452816","title":"PEGBIO CO-B Completes Full H-Share Conversion for Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1114452816","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114452816?lang=en_us&edition=fundamental","pubTime":"2026-06-26 13:40","pubTimestamp":1782452439,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (02565) has announced the successful completion of the conversion of 102 million non-traded shares into H-shares.The conversion was finalized on June 25, 2026.These newly converted H-shares commenced trading on the Hong Kong Stock Exchange starting at 9:00 AM on June 26, 2026.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK4581","BK4588","BK4585","XBI","161726","399441","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184250474","title":"PegBio Converts 101.70 Million Unlisted Shares into H Shares, Enlarging Hong Kong Free Float by 26%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184250474","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184250474?lang=en_us&edition=fundamental","pubTime":"2026-06-26 12:23","pubTimestamp":1782447837,"startTime":"0","endTime":"0","summary":"On 26 June 2026, PegBio Co., Ltd. (abbreviated as “PegBio”) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, confirming the conversion of 101.70 million unlisted shares into H...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645892645","title":"Pegbio Appoints Yik Lam Liao as Independent Director, Names Her Audit Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2645892645","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645892645?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:55","pubTimestamp":1782298540,"startTime":"0","endTime":"0","summary":"PegBio appoints Yik Lam Liao as independent director, names her audit chairPegBio appointed Yik Lam Liao as an independent non-executive director, effective June 24, 2026, following shareholder voting","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL4gfpMx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183413158","title":"Movement Alert｜Pegbio Biopharmaceuticals-B Falls 8.23% in Regular Trading, Litigation Risk and Sector Weakness Intensify Selling Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1183413158","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183413158?lang=en_us&edition=fundamental","pubTime":"2026-06-16 11:47","pubTimestamp":1781581627,"startTime":"0","endTime":"0","summary":"On June 16, Pegbio Biopharmaceuticals-B declined 8.23% in regular trading, trading at HK$6.48/share, with turnover of HK$35.48 million. The stock hit a fresh 52-week low amid persistent market...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641510319","title":"PegBio Receives HK$61 Million in Royalty Payment Over Drug Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2641510319","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641510319?lang=en_us&edition=fundamental","pubTime":"2026-06-08 12:31","pubTimestamp":1780893062,"startTime":"0","endTime":"0","summary":"PegBio  received the first royalty payment of HK$61 million from Shanghai Tenry Pharmaceutical over a licensing deal covering visepegenatide in China, according to a Friday filing with the Hong Kong bourse.The medicine, sold under the Paidakang brand name, is intended to treat type 2 diabetes.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141451062","title":"Movement Alert｜PegBio Rises 8.37% in Regular Trading, Boosted by HKD 61 Million Commercialization Milestone Payment from Tengrui Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1141451062","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141451062?lang=en_us&edition=fundamental","pubTime":"2026-06-08 10:22","pubTimestamp":1780885359,"startTime":"0","endTime":"0","summary":"On June 8, PegBio (Peg Bio Pharmaceuticals-B) rose 8.37% in regular trading, trading at HKD 8.4 per share, with trading volume of approximately HKD 93.36 million.On the news front, the company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":115,"code":"91000000","status":"200"}]}}